Clincosm LogoSign in Get a demo

advanced solid tumor

Showing NaN - NaN of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Advanced Solid Tumor Trial in Canada, Denmark, United States (RP-6306, RP-3500)

Recruiting
  • Advanced Solid Tumor
  • New Haven, Connecticut
  • +11 more
Apr 25, 2022

Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in United States (BTX-1188)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Duarte, California
  • +3 more
Apr 18, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Advanced Solid Tumor Trial in New York, Beijing, Shanghai (NB003 tablets)

Recruiting
  • Advanced Solid Tumor
  • NB003 tablets
  • New York, New York
  • +2 more
Jan 29, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Advanced Solid Tumor Trial in Worldwide (CLR457)

Terminated
  • Advanced Solid Tumor
  • Boston, Massachusetts
  • +6 more
Dec 2, 2021

Advanced Solid Tumor, NSCLC, Colorectal Cancer Trial in Australia, United States (LY3499446, Abemaciclib, Cetuximab)

Terminated
Has Results
  • Advanced Solid Tumor
  • +2 more
  • Indianapolis, Indiana
  • +5 more
Oct 27, 2021

Advanced Solid Tumor Trial in Whittier, New York, Houston (YL-15293)

Recruiting
  • Advanced Solid Tumor
  • Whittier, California
  • +2 more
Nov 11, 2021

Advanced Solid Tumor Trial in Australia, New Zealand, United States (BGB-15025, Tislelizumab)

Recruiting
  • Advanced Solid Tumor
  • New York, New York
  • +5 more
Nov 2, 2021

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Santa Monica, California
  • +4 more
Sep 15, 2021

Advanced Solid Tumor, Solid Tumor Trial in United States (ARX517)

Recruiting
  • Advanced Solid Tumor
  • Solid Neoplasm
  • Los Angeles, California
  • +7 more
Aug 24, 2021

Advanced Solid Tumor, NSCLC Recurrent, Squamous Cell Carcinoma of Head and Neck Trial in Germany, United States (DRP-104,

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Scottsdale, Arizona
  • +8 more
Jun 20, 2021

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
Has Results
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021

Advanced Solid Tumor, Lymphomas Trial in France, Netherlands, United States (LEE011)

Completed
  • Advanced Solid Tumor
  • Lymphomas
  • Boston, Massachusetts
  • +6 more
Dec 16, 2020

Advanced Solid Tumor, Lymphoma Trial in United States (Milademetan)

Completed
  • Advanced Solid Tumor
  • Lymphoma
  • Detroit, Michigan
  • +4 more
Dec 4, 2020

Hepatoma, Advanced Solid Tumor Trial in New York (irinotecan and ON 01910.Na, oxaliplatin and ON 01910.Na)

Completed
  • Hepatoma
  • Advanced Solid Tumor
  • irinotecan and ON 01910.Na
  • oxaliplatin and ON 01910.Na
  • New York, New York
    Mount Sinai Medical Center
Jun 22, 2017